Innospec Inc

Basic Materials · Specialty Chemicals

98.70$ +1.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Innospec Inc (IOSP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 491 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IOSP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	206	238	294	326	332	354	361	358	363	395	388	362	372	391	372	245	265	311	340	355	376	413	472	468	513	511	510	480	464	495	500	435	443	467	441	440	442	456	453	491	1,842
Cost of Revenue	126	146	203	221	234	245	256	255	252	278	271	251	253	273	258	186	186	220	239	246	263	300	333	328	357	359	362	330	327	339	345	308	319	331	316	317	325	328	330	353	1,336
Gross Profit	79	91	91	105	99	109	105	103	111	117	118	111	119	118	114	59	79	91	101	108	113	113	139	140	156	152	148	150	137	156	156	127	124	136	125	123	117	127	124	138	506
Research & Development	6.5	5.8	7.4	8.5	7.9	7.6	8.3	8.7	8.1	8.3	9.1	8.2	9.7	8.4	8.6	8.1	7.7	6.5	9.0	8.6	10	9.5	10	10	10	8.4	11	11	12	8.9	14	14	11	13	13	14	14	11	13	14	52
Selling, General & Administrative	56	56	55	61	62	64	67	66	65	63	73	71	71	66	64	64	54	237	64	63	71	70	85	83	96	625	95	104	82	102	89	72	65	228	69	75	72	69	79	84	304
Total Operating Expenses	63	62	63	69	69	70	76	75	73	72	82	79	81	74	73	113	62	62	73	71	82	77	95	94	106	105	107	116	95	111	105	86	79	95	83	89	86	80	92	99	356
Operating Income	19	32	26	35	30	38	29	28	33	43	36	32	38	44	41	-53	17	29	28	37	31	36	44	46	50	47	41	34	42	45	51	41	46	41	43	34	31	47	32	40	150
Interest Expense	0.7	1.0	2.2	2.0	2.1	1.9	1.7	1.8	1.8	1.6	1.5	1.2	1.4	0.7	0.6	0.5	0.4	0.3	0.4	0.3	0.4	0.4	0.4	0.4	0.3	2.2	0.3	0.3	0.8	0.9	–	2.1	–	–	–	–	–	–	–	–	–
Pre-Tax Income	13	29	23	35	30	40	30	30	30	42	39	31	38	43	44	-54	20	29	31	40	31	33	48	42	49	45	45	37	48	45	55	44	45	-103	44	32	12	50	40	42	143
Income Tax Expense	1.8	6.9	6.0	8.7	6.6	45	7.5	7.7	9.8	22	10	8.2	7.7	12	11	-14	7.5	6.5	7.4	18	7.4	8.8	12	10	10	20	12	7.7	8.3	7.5	14	13	11	-32	12	8.4	-1.4	2.9	9.1	10	21
Net Income	11	22	17	26	23	-4.8	22	22	21	20	29	22	30	31	33	-40	13	23	23	22	23	24	37	32	39	26	33	29	39	38	41	31	33	-70	33	24	13	47	30	31	122
EBITDA	29	41	38	49	45	55	44	45	47	57	52	44	52	55	57	-41	32	40	42	51	42	45	59	53	59	54	52	46	54	56	63	52	59	48	54	46	23	60	50	39	172

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings